194 related articles for article (PubMed ID: 26910117)
21. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for metastasis and poor prognosis of Ewing sarcoma: a population based study.
Shi J; Yang J; Ma X; Wang X
J Orthop Surg Res; 2020 Mar; 15(1):88. PubMed ID: 32131863
[TBL] [Abstract][Full Text] [Related]
23. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study.
Tang X; Zhou X; Li Y; Tian X; Wang Y; Huang M; Ren L; Zhou L; Ding Z; Zhu J; Xu Y; Peng F; Wang J; Lu Y; Gong Y
Ann Surg Oncol; 2019 Feb; 26(2):321-328. PubMed ID: 30357578
[TBL] [Abstract][Full Text] [Related]
24. Independent risk factors evaluation for overall survival and cancer-specific survival in thyroid cancer patients with bone metastasis: A study for construction and validation of the predictive nomogram.
Tong Y; Huang Z; Hu C; Chi C; Lv M; Li P; Zhao C; Song Y
Medicine (Baltimore); 2020 Sep; 99(36):e21802. PubMed ID: 32899008
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: A population-based study using the SEER 18 database.
Meng K; Luo H; Chen H; Guo H; Xia W
Medicine (Baltimore); 2019 Jan; 98(1):e13884. PubMed ID: 30608412
[TBL] [Abstract][Full Text] [Related]
26. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
Kim SJ; Myong JP; Suh H; Lee KE; Youn YK
PLoS One; 2015; 10(6):e0130848. PubMed ID: 26102084
[TBL] [Abstract][Full Text] [Related]
27. Is Age ≥ 55 years an optimal cutoff point among patients with differentiated thyroid Microcarcinoma? a preliminary study.
Min Y; Feng Y; He D; Zeng X; Fan S; Luo H; Yin G; Hu D
Oral Oncol; 2022 Jul; 130():105938. PubMed ID: 35653818
[TBL] [Abstract][Full Text] [Related]
28. The Establishment and Verification of a Nomogram Model for Predicting the Overall Survival of Medullary Thyroid Carcinoma: An Analysis Based on the SEER Database.
Wang W; Wang X; Che G; Qiao J; Chen Z; Liu J
Curr Oncol; 2023 Dec; 31(1):84-96. PubMed ID: 38248091
[TBL] [Abstract][Full Text] [Related]
29. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases.
Roman S; Lin R; Sosa JA
Cancer; 2006 Nov; 107(9):2134-42. PubMed ID: 17019736
[TBL] [Abstract][Full Text] [Related]
30. Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study.
Xiang N; Dong F; Zhan X; Wang S; Wang J; Sun E; Chen B
BMC Endocr Disord; 2021 Apr; 21(1):68. PubMed ID: 33849490
[TBL] [Abstract][Full Text] [Related]
31. Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.
Jung KY; Kim SM; Yoo WS; Kim BW; Lee YS; Kim KW; Lee KE; Jeong JJ; Nam KH; Lee SH; Hah JH; Chung WY; Yi KH; Park DJ; Youn YK; Sung MW; Cho BY; Park CS; Park YJ; Chang HS
Clin Endocrinol (Oxf); 2016 Apr; 84(4):587-97. PubMed ID: 26175307
[TBL] [Abstract][Full Text] [Related]
32. Nomograms for predicting the overall and cancer-specific survival of patients with classical Hodgkin lymphoma: a SEER-based study.
Zhang Y; Zhang J; Zeng H; Zhou XH; Zhou HB
Oncotarget; 2017 Nov; 8(54):92978-92988. PubMed ID: 29190971
[TBL] [Abstract][Full Text] [Related]
33. Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997-2014: A Nationwide Study.
Mathiesen JS; Kroustrup JP; Vestergaard P; Stochholm K; Poulsen PL; Rasmussen ÅK; Feldt-Rasmussen U; Schytte S; Londero SC; Pedersen HB; Hahn CH; Bentzen J; Möller S; Gaustadnes M; Rossing M; Nielsen FC; Brixen K; Frederiksen AL; Godballe C
Thyroid; 2019 Mar; 29(3):368-377. PubMed ID: 30618340
[TBL] [Abstract][Full Text] [Related]
34. Five- and 10-Year Cause-Specific Survival Rates in Carcinoma of the Minor Salivary Gland.
Baddour HM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):67-73. PubMed ID: 26632951
[TBL] [Abstract][Full Text] [Related]
35. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
36. Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study.
Jiao Z; Wu T; Jiang M; Jiang S; Jiang K; Peng J; Luo G; Yu Y; Chen W; Yang A
Front Endocrinol (Lausanne); 2022; 13():1094242. PubMed ID: 36589824
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes for older patients with papillary thyroid carcinoma: should another age cutoff beyond 45 years be added?
Lang BH; Lo CY; Wong KP; Wan KY
Ann Surg Oncol; 2015 Feb; 22(2):446-53. PubMed ID: 25190130
[TBL] [Abstract][Full Text] [Related]
38. The impact of marital status at diagnosis on cancer survival in patients with differentiated thyroid cancer.
Shi RL; Qu N; Lu ZW; Liao T; Gao Y; Ji QH
Cancer Med; 2016 Aug; 5(8):2145-54. PubMed ID: 27264532
[TBL] [Abstract][Full Text] [Related]
39. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy.
Kwon H; Kim WG; Jeon MJ; Song DE; Lee YM; Sung TY; Chung KW; Yoon JH; Hong SJ; Baek JH; Lee JH; Kim TY; Kim WB; Shong YK
Endocrine; 2016 Jul; 53(1):174-81. PubMed ID: 26754662
[TBL] [Abstract][Full Text] [Related]
40. Small Cell Carcinoma: a Rare Subtype of Thyroid Cancer with Unanticipated Prognosis.
Shi W; Zhao QY; Liu ZM; Wang ST; Liu CP
Curr Med Sci; 2019 Apr; 39(2):265-269. PubMed ID: 31016520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]